Peter J. Bungay

1.4k citations

35 papers · 948 indexed · h-index 18

Co-authors: Martin Griffin Louise H. Naylor J. Potter Sharan K. Bagal B.M. Elliott Samuel E. George Gary G. Kay Jennifer L. LaPerle
Topics: Pancreatic function and diabetes (8 papers)Blood properties and coagulation (6 papers)Receptor Mechanisms and Signaling (6 papers)
Cited by: Pharmaceutical Science Pharmacology Urology
Journals: Biochemistry Biochemical Journal Journal of Medicinal Chemistry
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Peter J. Bungay

34 papers receiving 925 citations

Peers

Countries citing papers authored by Peter J. Bungay

Since Specialization

Citations

This map shows the geographic impact of Peter J. Bungay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Bungay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Bungay more than expected).

Fields of papers citing papers by Peter J. Bungay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Bungay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Bungay. The network helps show where Peter J. Bungay may publish in the future.

Co-authorship network of co-authors of Peter J. Bungay

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Bungay. A scholar is included among the top collaborators of Peter J. Bungay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Bungay. Peter J. Bungay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of pain 2018 ·Bioorganic & Medicinal Chemistry ·Alan D. Brown,Sharan K. Bagal,(unknown),David C. Blakemore,B. Greg Brown,Peter J. Bungay,(unknown),James Crawforth,(unknown),David R. Fenwick,(unknown),Mark I. Kemp,Wolfgang Klute,(unknown),Duncan C. Miller,(unknown),(unknown),S. Skerratt,Edward B. Stevens,Joseph S. Warmus	22
2	Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS 2016 ·International Journal of Pharmaceutics ·Anne-Laure Lainé,Daniel J. Price,(unknown),(unknown),Richard Hudson,Kevin Back,Peter J. Bungay,(unknown)	57
3	Discovery and Optimization of Selective Na _v 1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of Pain 2015 ·ACS Medicinal Chemistry Letters ·Sharan K. Bagal,Peter J. Bungay,(unknown),Karl R. Gibson,(unknown),(unknown),Mark I. Kemp,(unknown),Mark L. Lewis,Graham N. Maw,(unknown),(unknown),(unknown),David J. Rawson,Blanda Stammen,Edward B. Stevens,Lisa R. Thompson	36
4	Restricting CNS penetration of drugs to minimise adverse events: role of drug transporters 2014 ·Drug Discovery Today Technologies ·Sharan K. Bagal,Peter J. Bungay	14
5	Preclinical and Clinical Pharmacokinetics of PF-02413873, a Nonsteroidal Progesterone Receptor Antagonist 2011 ·Drug Metabolism and Disposition ·Peter J. Bungay,(unknown),David Howe,Karl R. Gibson,Hannah M. Jones,Natalie Mount	18
6	A comprehensive non‐clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder 2011 ·British Journal of Clinical Pharmacology ·Ernesto Callegari,Bimal Malhotra,Peter J. Bungay,Rob Webster,Katherine S. Fenner,Sarah Kempshall,Jennifer L. LaPerle,Martin C. Michel,Gary G. Kay	111
7	The Translational Efficacy of a Nonsteroidal Progesterone Receptor Antagonist, 4-[3-Cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on Endometrial Growth in Macaque and Human 2011 ·Journal of Pharmacology and Experimental Therapeutics ·David Howe,Natalie Mount,(unknown),Amy Brown,Peter J. Bungay,Karl R. Gibson,(unknown),(unknown),Gareth Jones,Rosalind Walley,Alison McLeod,(unknown),(unknown),(unknown),Nick Pullen	1
8	In Vitro Metabolism, Permeability, and Efflux of Bazedoxifene in Humans 2010 ·Drug Metabolism and Disposition ·Li Shen,(unknown),(unknown),William DeMaio,Aram Oganesian,(unknown),JoAnn Scatina,Peter J. Bungay,Appavu Chandrasekaran	19
9	The Translational Pharmacology of a Novel, Potent, and Selective Nonsteroidal Progesterone Receptor Antagonist, 2-[4-(4-Cyano-phenoxy)-3,5-dicyclopropyl-1 H-pyrazol-1-yl]-N-methylacetamide (PF-02367982) 2008 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),Peter J. Bungay,(unknown),(unknown),David A. Goodwin,Nick Pullen	8
10	Regulatory Roles of the N-Terminal Domain Based on Crystal Structures of Human Pyruvate Dehydrogenase Kinase 2 Containing Physiological and Synthetic Ligands ^, 2005 ·Biochemistry ·(unknown),Alec D. Tucker,(unknown),Chris Phillips,(unknown),Peter J. Bungay,Shane A. Kasten,Thomas E. Roche,David G. Brown	87
11	The Effect of ICER on Screening Methods Involving CRE-Mediated Reporter Gene Expression 2002 ·SLAS DISCOVERY ·Daniel M. Kemp,(unknown),Toby Kent,Peter J. Bungay,Louise H. Naylor	9
12	The Effect of ICER on Screening Methods Involving CRE-Mediated Reporter Gene Expression 2002 ·Daniel M. Kemp,(unknown),Toby Kent,Peter J. Bungay,Louise H. Naylor	1
13	Mixed connective tissue disease presenting with pneumonitis and pneumatosis intestinalis 2000 ·Arthritis & Rheumatism ·(unknown),Peter J. Bungay,B. Ronan O’Driscoll,Ariane L. Herrick	9
14	Functional Analysis of the D2L Dopamine Receptor Expressed in a cAMP-Responsive Luciferase Reporter Cell Line 1998 ·Biochemical Pharmacology ·(unknown),Peter J. Bungay,Louise H. Naylor	20
15	Functional Coupling of Endogenous Serotonin (5‐HT_1B) and Calcitonin (C1a) Receptors in CHO Cells to a Cyclic AMP‐Responsive Luciferase Reporter Gene 1997 ·Journal of Neurochemistry ·Samuel E. George,Peter J. Bungay,Louise H. Naylor	57
16	The combinatorial synthesis of a 30,752-compound library: discovery of SAR around the endothelin antagonist, FR-139,317 1995 ·Bioorganic & Medicinal Chemistry Letters ·N.K. Terrett,Dejan Bojanic,David Brown,Peter J. Bungay,Mark Gardner,David W. Gordon,(unknown),John Steele	35
17	Transglutaminase-catalysed cross-linking of proteins phosphorylated in the intact glucose-stimulated pancreatic β-cell 1988 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown),Peter J. Bungay,M. N. Hussain,Martin Griffin	9
18	A role for polyamines in stimulus-secretion coupling in the pancreatic β-cell 1984 ·Bioscience Reports ·Peter J. Bungay,J. Potter,Martin Griffin	21
19	Changes in transglutaminase activity during tumour growth and metastasis 1984 ·Biochemical Society Transactions ·(unknown),Peter J. Bungay,(unknown),(unknown),Martin Griffin	3
20	The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism 1984 ·Biochemical Journal ·Peter J. Bungay,J. Potter,Martin Griffin	43

About Peter J. Bungay

Peter J. Bungay is a scholar working on Pharmaceutical Science, Cellular and Molecular Neuroscience and Gastroenterology, having authored 35 papers that have together received 948 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (8 papers), Blood properties and coagulation (6 papers) and Receptor Mechanisms and Signaling (6 papers). The work is most often cited by research in Pharmaceutical Science (63 citations), Pharmacology (83 citations) and Urology (60 citations). Peter J. Bungay has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Martin Griffin, Louise H. Naylor, J. Potter, Sharan K. Bagal, B.M. Elliott, Samuel E. George, Gary G. Kay, Jennifer L. LaPerle, Martin C. Michel and Bimal Malhotra. Their work appears in journals such as Biochemistry, Biochemical Journal and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact